Search clinical trials for: Ixabepilone Capecitabine
Total 1943 results
-
R-PharmNational Cancer Institute (NCI)UnknownBreast CancerUnited States
-
R-PharmGlaxoSmithKlineTerminatedLocally Advanced or Metastatic Breast CancerUnited States, Italy, Australia
-
R-PharmTerminated
-
Weill Medical College of Cornell UniversityBristol-Myers SquibbCompletedMetastatic Breast CancerUnited States
-
R-PharmCompletedNeoplasms | Advanced Solid TumorsUnited States
-
R-PharmNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer CenterCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)CompletedLymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
R-PharmCompleted
-
Cedars-Sinai Medical CenterBristol-Myers SquibbTerminatedUrogenital Neoplasms | Adenocarcinoma | Carcinoma | Neoplasms, Glandular and Epithelial | Genital Neoplasms, Male | Prostatic Neoplasms | Prostatic Diseases | Genital Diseases, MaleUnited States
-
R-PharmCompletedCancer | Breast CancerTurkey, Chile, Belgium, Portugal, Spain, Italy, United States, Argentina, Austria, Brazil, Canada, France, Germany, Singapore, South Africa, Taiwan, United Kingdom, Israel, Australia, Korea, Republic of, Russian Federation, Ireland, Netherland... and more
-
R-PharmCompletedNovel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast CancerBreast Cancer | MetastasesBelgium, Spain, United States, Argentina, Brazil, Canada, Germany, Peru, Taiwan, United Kingdom, Italy, France, Korea, Republic of, Philippines, Thailand, Mexico, Sweden, China, Hungary, Poland, Greece, Malaysia
-
Eisai Inc.Completed
-
R-PharmCompletedSolid MalignanciesUnited States
-
R-PharmCompleted
-
R-PharmCompletedStomach NeoplasmsKorea, Republic of, Taiwan, Japan, Singapore, Hong Kong
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
R-PharmCompleted
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedSarcoma | Kidney Cancer | Unspecified Childhood Solid Tumor, Protocol Specific | Leukemia | Ovarian Cancer | Brain and Central Nervous System Tumors | Neuroblastoma | Liver Cancer | Extragonadal Germ Cell Tumor | Childhood Germ Cell TumorUnited States
-
University of Texas Southwestern Medical CenterNational Cancer Institute (NCI)WithdrawnProstate CancerUnited States
-
Montefiore Medical CenterNational Cancer Institute (NCI)CompletedOvarian Cancer | Peritoneal Cavity CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedTesticular Germ Cell Tumor | Ovarian Cancer | Brain and Central Nervous System Tumors | Extragonadal Germ Cell TumorUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedGastric Cancer | Esophageal CancerUnited States
-
University of Texas Southwestern Medical CenterWithdrawn
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
National Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Bristol-Myers SquibbNational Cancer Institute (NCI)CompletedGastric Cancer | Esophageal CancerUnited States
-
Allarity TherapeuticsRecruitingMetastatic Breast CancerFinland, Poland, Germany, United Kingdom, Belgium, Italy, Netherlands
-
Bristol-Myers SquibbCompleted
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
R-PharmCompletedBreast Cancer | MetastasesUnited States, Netherlands, Argentina, Canada, South Africa, Mexico, Norway, Sweden, France, Germany
-
Consorzio OncotechCompleted
-
National Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
SCRI Development Innovations, LLCBristol-Myers Squibb; BayerCompletedMetastatic Breast CancerUnited States
-
Dutch Colorectal Cancer GroupSanofi; Roche Pharma AG; Koningin Wilhelmina Fonds; ImmuniconCompletedColorectal CancerNetherlands
-
Federation Francophone de Cancerologie DigestiveRecruiting
-
US Oncology ResearchBristol-Myers SquibbCompleted
-
R-PharmCompletedMetastatic Breast Cancer | Triple Negative Locally Advanced Non-resectable Breast CancerCzech Republic, Italy, Poland, Spain, Austria, France, Greece
-
The Methodist Hospital Research InstituteBristol-Myers SquibbCompleted
-
University of ChicagoNational Cancer Institute (NCI)CompletedColorectal CancerUnited States
-
Masonic Cancer Center, University of MinnesotaGlaxoSmithKlineTerminatedSarcoma | Kidney Cancer | Breast Cancer | Head and Neck Cancer | Pancreatic Cancer | Lung Cancer | Colon Cancer | Hepatocellular CancerUnited States
-
Sun Yat-sen UniversityChengdu Biostar PharmaceuticalsNot yet recruitingBreast Neoplasms | Locally Advanced or Metastatic Breast CancerChina
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)Withdrawn
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Hoffmann-La RocheCompletedBreast Cancer, Colorectal CancerNew Zealand, Australia, United Kingdom
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Amgen; Susan G. Komen Breast Cancer FoundationWithdrawnBreast Cancer | Metastatic Breast Cancer | Stage IV Breast CancerUnited States
-
Cyclacel Pharmaceuticals, Inc.CompletedAcute Myeloid LeukemiaUnited States